Muss Hb

559 total citations
18 papers, 454 citations indexed

About

Muss Hb is a scholar working on Oncology, Reproductive Medicine and Immunology. According to data from OpenAlex, Muss Hb has authored 18 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Reproductive Medicine and 4 papers in Immunology. Recurrent topics in Muss Hb's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Muss Hb is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Muss Hb collaborates with scholars based in United States and Canada. Muss Hb's co-authors include DA Bass, LR DeChatelet, PS Shirley, Frederick Richards, Spurr Cl, Cooper Mr, Matthew Poole, Capizzi Rl, Gretchen Kimmick and Robert H. Choplin and has published in prestigious journals such as Blood, Cancer Research and American Journal of Roentgenology.

In The Last Decade

Muss Hb

18 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muss Hb United States	10	123	116	105	102	76	18	454
Tatsuro Kishida Japan	19	204 1.7×	99 0.9×	30 0.3×	153 1.5×	141 1.9×	38	762
Joanna Osada Poland	15	53 0.4×	50 0.4×	171 1.6×	68 0.7×	68 0.9×	37	445
Melissa A. Merideth United States	15	69 0.6×	85 0.7×	69 0.7×	139 1.4×	95 1.3×	36	635
Jesper Haaning Denmark	9	44 0.4×	144 1.2×	39 0.4×	119 1.2×	33 0.4×	16	486
Charlotte Floridon Denmark	14	130 1.1×	58 0.5×	32 0.3×	185 1.8×	118 1.6×	18	654
G Sébahoun France	14	46 0.4×	183 1.6×	151 1.4×	73 0.7×	240 3.2×	61	585
C. M. Towler United Kingdom	13	84 0.7×	52 0.4×	43 0.4×	108 1.1×	87 1.1×	17	442
Sam Milliken Australia	12	72 0.6×	90 0.8×	158 1.5×	57 0.6×	116 1.5×	31	576
SylviaD. Lawler United Kingdom	15	514 4.2×	398 3.4×	51 0.5×	176 1.7×	115 1.5×	37	1.0k
I. Yaniv Israel	14	102 0.8×	125 1.1×	48 0.5×	122 1.2×	37 0.5×	29	471

Countries citing papers authored by Muss Hb

Since Specialization

Citations

This map shows the geographic impact of Muss Hb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muss Hb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muss Hb more than expected).

Fields of papers citing papers by Muss Hb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muss Hb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muss Hb. The network helps show where Muss Hb may publish in the future.

Co-authorship network of co-authors of Muss Hb

This figure shows the co-authorship network connecting the top 25 collaborators of Muss Hb. A scholar is included among the top collaborators of Muss Hb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muss Hb. Muss Hb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wagoner, Chad W., et al.. (2023). Association of self-directed walking with toxicity moderation during chemotherapy for the treatment of early breast cancer. Supportive Care in Cancer. 32(1). 68–68. 3 indexed citations

Hurria, Arti, Allison Magnuson, Muss Hb, et al.. (2019). Abstract GS6-04: Development and validation of a chemotherapy toxicity (Chemo Tox) risk score for older patients (Pts) with breast cancer (BC) receiving adjuvant/neoadjuvant treatment (Adjuvant Tx): A R01 and BCRF funded prospective multicenter study. Cancer Research. 79(4_Supplement). GS6–4. 11 indexed citations

Keating, NL, Alice B. Kornblith, Jeanne S. Mandelblatt, et al.. (2012). Abstract P6-08-05: Changes in Cognitive Function in Older Women With Breast Cancer Treated with Standard Chemotherapy and Capecitabine within CALGB 49907. Cancer Research. 72(24_Supplement). P6–8. 1 indexed citations

Hb, Muss. (1995). Breast Cancer in the Elderly: Treatment of Metastatic Disease.. PubMed. 2(2 Suppl 1). 39–42. 1 indexed citations

Hb, Muss, et al.. (1995). Age and Gynecologic Cancer: The Gynecologic Oncology Group Experience.. PubMed. 2(2 Suppl 1). 17–18. 1 indexed citations

Kimmick, Gretchen & Muss Hb. (1995). Current status of endocrine therapy for metastatic breast cancer.. PubMed. 9(9). 877–86, 889. 17 indexed citations

Hb, Muss. (1995). Chemotherapy of breast cancer in the older patient.. PubMed. 22(1 Suppl 1). 14–6. 13 indexed citations

Hb, Muss. (1994). Chemotherapy of metastatic endometrial cancer.. PubMed. 21(1). 107–13. 38 indexed citations

Hb, Muss, et al.. (1987). Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.. PubMed. 71(2). 217–8. 12 indexed citations

10.

Rl, Capizzi, Matthew Poole, Cooper Mr, et al.. (1984). Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.. PubMed. 63(3). 694–700. 159 indexed citations

11.

Choplin, Robert H., et al.. (1983). Multiple primary bronchogenic carcinomas of the lung. American Journal of Roentgenology. 140(2). 253–258. 24 indexed citations

12.

Hb, Muss, et al.. (1978). Vinblastine and 6-thioguanine in the treatment of advanced breast cancer.. PubMed. 62(8). 1233–5. 2 indexed citations

13.

DeChatelet, LR, et al.. (1978). Comparison of intracellular bactericidal activities of human neutrophils and eosinophils. Blood. 52(3). 609–617. 1 indexed citations

14.

DeChatelet, LR, et al.. (1978). Comparison of intracellular bactericidal activities of human neutrophils and eosinophils. Blood. 52(3). 609–617. 41 indexed citations

15.

Haid, Max, et al.. (1977). Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 50(1). 103–5. 7 indexed citations

16.

DeChatelet, LR, et al.. (1977). Oxidative metabolism of the human eosinophil. Blood. 50(3). 525–535. 9 indexed citations

17.

DeChatelet, LR, et al.. (1977). Oxidative metabolism of the human eosinophil. Blood. 50(3). 525–535. 107 indexed citations

18.

Hb, Muss, et al.. (1976). Adriamycin and CCNU in the treatment of advanced breast cancer.. PubMed. 60(11). 1687–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact